This protocol is judged by an institutional evaluation board, an impartial group that critiques any clinical trials involving humans. If a study includes a Plan I drug, after the board approves the protocol as moral, the researchers need to make an application for an investigational new drug (IND) variety from your FDA.“It’s important to keep i